Authors:
SCHMITT G
SAUVANET A
BERTHOUX L
VALVERDE A
DUGUE L
FEKETE F
BELGHITI J
Citation: G. Schmitt et al., PALLIATIVE TREATMENT FOR ADENOCARCINOMA OF THE CARDIA - IS THERE A PLACE FOR SURGERY, Gastroenterologie clinique et biologique, 22(8-9), 1998, pp. 669-674
Citation: F. Essodegui et al., LATE PERFORATION OF THE PRESTERNAL ESOPHA GOCOLOPLASTY - ROLE OF SONOGRAPHY, Journal de radiologie, 79(2), 1998, pp. 163-165
Authors:
HEIDET L
BOYE E
CAI Y
SADO Y
ZHANG X
FLEJOU JF
FEKETE F
NINOMIYA Y
GUBLER MC
ANTIGNAC C
Citation: L. Heidet et al., SOMATIC DELETION OF THE 5'-END OF BOTH THE COL4A5 AND COL4A6 GENES INA SPORADIC LEIOMYOMA OF THE ESOPHAGUS, The American journal of pathology, 152(3), 1998, pp. 673-678
Authors:
JELLISON J
CONNOLLY J
GOODELL B
DOYLE B
ILLMAN B
FEKETE F
OSTROFSKY A
Citation: J. Jellison et al., THE ROLE OF CATIONS IN THE BIODEGRADATION OF WOOD BY THE BROWN-ROT FUNGI, International biodeterioration & biodegradation, 39(2-3), 1997, pp. 165-179
Authors:
MARTON A
NAGY A
KATONA G
FEKETE F
VOTISKY P
LAJOS Z
Citation: A. Marton et al., NOSOCOMIAL STREPTOCOCCUS-PNEUMONIAE INFECTION CAUSING CHILDRENS ACUTEOTITIS-MEDIA, International journal of antimicrobial agents, 8(1), 1997, pp. 29-35
Citation: F. Fekete et al., ROUX-EN-Y DUODENAL DIVERSION FOR COMPLEX GASTROESOPHAGEAL REFLUX DISEASE, Gastroenterologie clinique et biologique, 21(11), 1997, pp. 823-831
Authors:
GOODELL B
JELLISON J
LIU J
DANIEL G
PASZCZYNSKI A
FEKETE F
KRISHNAMURTHY S
JUN L
XU G
Citation: B. Goodell et al., LOW-MOLECULAR-WEIGHT CHELATORS AND PHENOLIC-COMPOUNDS ISOLATED FROM WOOD DECAY FUNGI AND THEIR ROLE IN THE FUNGAL BIODEGRADATION OF WOOD, Journal of biotechnology, 53(2-3), 1997, pp. 133-162
Authors:
FEKETE F
LORTATJACOB JL
RICHARD CA
MAILLARD JN
Citation: F. Fekete et al., CURRENT TREATMENT OF CANCER OF THE ESOPHA GUS (REPRINTED FROM ANN CHIR, VOL 16, PG 977-983, 1962), Annales de chirurgie, 51(5), 1997, pp. 556-559
Authors:
LORTATJACOB JL
CACHERA JP
MAILLARD JN
RICHARD CA
FEKETE F
Citation: Jl. Lortatjacob et al., 10 YEARS EXPERIENCE OF THE SURGICAL-TREAT MENT OF GASTRIC CANCERS - COMPLETE HOSPITAL STATISTICS CONCERNING 300 CASES (REPRINTED FROM ANN CHIR, VOL 16, PG 999-1015, 1962), Annales de chirurgie, 51(5), 1997, pp. 567-568
Citation: F. Fekete et A. Sauvanet, THE SURGEONS POINT-OF-VIEW ON PREOPERATIV E ASSESSMENT OF GASTROESOPHAGEAL REFLUX, Annales de chirurgie, 51(3), 1997, pp. 207-211
Authors:
SAUVANET A
BERTHOUX L
GAYET B
FLEJOU JF
BELGHITI J
FEKETE F
Citation: A. Sauvanet et al., ADENOCARCINOMA OF THE CARDIA - DOES EXTEN T OF GASTRECTOMY AND LYMPHADENECTOMY INFLUENCE SURVIVAL, Gastroenterologie clinique et biologique, 19(3), 1995, pp. 244-251
Authors:
PARAF F
FLEJOU JF
PIGNON JP
FEKETE F
POTET F
Citation: F. Paraf et al., SURGICAL PATHOLOGY OF ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS - ANALYSIS OF 67 CASES, The American journal of surgical pathology, 19(2), 1995, pp. 183-191
Citation: F. Fekete, RESULTS OF MODIFIED LAPAROSCOPIC HILL OPE RATION IN A SERIES OF 50 CASES - DISCUSSION, Annales de chirurgie, 49(1), 1995, pp. 44-46
Authors:
BELGHITI J
DICARLO I
SAUVANET A
URIBE M
FEKETE F
Citation: J. Belghiti et al., A 10-YEAR EXPERIENCE WITH HEPATIC RESECTION IN 338 PATIENTS - EVOLUTIONS IN INDICATIONS AND OF OPERATIVE MORTALITY, The European journal of surgery, 160(5), 1994, pp. 277-282
Citation: Jf. Flejou et al., PROGNOSTIC FACTORS OF BARRETTS ADENOCARCINOMA, Gastroenterologie clinique et biologique, 18(1BIS), 1994, pp. 40000063-40000066
Authors:
FLEJOU JF
MUZEAU F
POTET F
LEPELLETIER F
FEKETE F
HENIN D
Citation: Jf. Flejou et al., OVEREXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE-PRODUCT IN ESOPHAGEALAND GASTRIC CARCINOMAS, Pathology research and practice, 190(12), 1994, pp. 1141-1148
Authors:
FLEJOU JF
PARAF F
POTET F
MUZEAU F
FEKETE F
HENIN D
Citation: Jf. Flejou et al., P53 PROTEIN EXPRESSION IN BARRETTS ADENOCARCINOMA - A FREQUENT EVENT WITH NO PROGNOSTIC-SIGNIFICANCE, Histopathology, 24(5), 1994, pp. 487-489
Authors:
PANIS Y
BELGHITI J
VALLA D
BENHAMOU JP
FEKETE F
Citation: Y. Panis et al., PORTOSYSTEMIC SHUNT IN BUDD-CHIARI SYNDROME - LONG-TERM SURVIVAL AND FACTORS AFFECTING SHUNT PATENCY IN 25 PATIENTS IN WESTERN COUNTRIES, Surgery, 115(3), 1994, pp. 276-281
Authors:
FLEJOU JF
PARAF F
MUZEAU F
FEKETE F
HENIN D
JOTHY S
POTET F
Citation: Jf. Flejou et al., EXPRESSION OF C-ERBB-2 ONCOGENE PRODUCT IN BARRETTS ADENOCARCINOMA - PATHOLOGICAL AND PROGNOSTIC CORRELATIONS, Journal of Clinical Pathology, 47(1), 1994, pp. 23-26